Chlamydia Trachomatis anticorps (Biotin)

N° du produit ABIN112697

L’anticorps Chèvre Polyclonal anti-Chlamydia Trachomatis a été validé pour WB et EIA. Il convient pour détecter Chlamydia Trachomatis dans des échantillons de Chlamydia trachomatis.

Aperçu rapide pour Chlamydia Trachomatis anticorps (Biotin) (ABIN112697)

Antigène: Chlamydia Trachomatis

Reactivité: Chlamydia trachomatis

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp Chlamydia Trachomatis est conjugé à/à la Biotin

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Détail du produit anti-Chlamydia Trachomatis anticorps (Biotin)

Immunogène: Purified MOMP from strain L2

Information d'application

Indications d'application: Suitable for use with avidin and streptavidin amplification systems for fluorescencemicroscopy.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 4-5 mg/mL (OD280 nm, E0.1% = 1.4)

Buffer: 0.01 M PBS, pH 7.2 containing 0.09 % sodium azide as preservative. Without stabilizer.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détails sur Chlamydia Trachomatis

Antigène: Chlamydia Trachomatis

Classe de substances: Bacteria

Sujet: Chlamydia trachomatis is an intracellular organism. Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men. Chlamydial infections are believed to be one of the most common of all STDs. It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year. Thus, there are many undiagnosed cases of chlamydia in the community. It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5 % to 10 %. Chlamydia is one of the leading causes of blindness in underdeveloped countries.